MedTrace Logo

Biochemical and Radiological Indicators of Cardiovascular Morbidity in Children With Premature Pubarche

NCT00581490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2017-04-04

No results posted yet for this study

Summary

Children with premature pubarche will have radiological and radial artery tonometry evidence of cardiovascular morbidity at diagnosis when compared to matched controls.

Conditions

  • Evidence of Cardiovascular Morbidity

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Revi P. Mathew, M.D. · Vanderbilt University

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581490 on ClinicalTrials.gov